Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Innate lymphoid cells type 1 may contribute to alopecia areata.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Hair follicles prevent NK cell attacks to avoid hair loss.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Engineered extracellular vesicles can improve tissue repair and regeneration.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

Exosomes could improve skin care, but more research is needed to confirm their safety and effectiveness.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

Different genes are active in dogs' hair growth and skin, similar to humans, which helps understand dog skin and hair diseases and can relate to human conditions.

Hair follicles help skin immune recovery after UVB exposure.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Topical immunotherapy is the best treatment for severe alopecia areata.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

COVID-19 may trigger hair loss conditions like alopecia areata.

CRISPR/Cas9 gene-editing may effectively treat hair loss but requires more research for safe use.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Bio-nanovesicles could improve hair and skin regeneration by delivering important molecules to repair and heal.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.